{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:58:08Z","timestamp":1783749488542,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2025.12.020","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:33:03Z","timestamp":1766125983000},"page":"3784-3801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters"],"prefix":"10.1016","volume":"16","author":[{"given":"Chenchen","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0536-620X","authenticated-orcid":false,"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-3160","authenticated-orcid":false,"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.020_bib1","series-title":"COVID-19 epidemiological update, edition 177","year":"2025"},{"key":"10.1016\/j.apsb.2025.12.020_bib2","unstructured":"WHO. Number of COVID-19 cases reported to WHO (cumulative total). Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases. (Accessed 30.3)."},{"key":"10.1016\/j.apsb.2025.12.020_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annepidem.2021.02.012","article-title":"COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis","volume":"57","author":"Macedo","year":"2021","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.apsb.2025.12.020_bib4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2025.12.020_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.020_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41392-025-02208-9","article-title":"Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial","volume":"10","author":"Bian","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.12.020_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.12.020_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add7197","article-title":"Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.12.020_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl4013","article-title":"In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.12.020_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2025.12.020_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.020_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2023.08.001","article-title":"Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2","volume":"4","author":"Hirotsu","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.apsb.2025.12.020_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13238-020-00768-w","article-title":"Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2","volume":"11","author":"Xiong","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2025.12.020_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116069","article-title":"Broad-spectrum antiviral strategy: host-targeting antivirals against emerging and re-emerging viruses","volume":"265","author":"He","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.020_bib15","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1080\/15548627.2020.1817280","article-title":"Coronavirus interactions with the cellular autophagy machinery","volume":"16","author":"Miller","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.12.020_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1515\/hsz-2016-0288","article-title":"The class III phosphatidylinositol 3-kinase Vps34 in Saccharomyces cerevisiae","volume":"398","author":"Reidick","year":"2017","journal-title":"Biol Chem"},{"key":"10.1016\/j.apsb.2025.12.020_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tcb.2015.05.004","article-title":"Beclin orthologs: integrative hubs of cell signaling, membrane trafficking, and physiology","volume":"25","author":"Levine","year":"2015","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.020_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110049","article-title":"Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation","volume":"37","author":"Twu","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.12.020_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01537-21","article-title":"Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues","volume":"95","author":"Shang","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2025.12.020_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2025.12.020_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7881","article-title":"Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1\/PD-L1 immunotherapy","volume":"6","author":"Noman","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.12.020_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29160","article-title":"Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants","volume":"95","author":"Feng","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.apsb.2025.12.020_bib23","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.apsb.2025.02.028","article-title":"Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.020_bib24","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1016\/j.apsb.2025.09.033","article-title":"Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.020_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41586-022-04835-6","article-title":"The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle","volume":"606","author":"Ricciardi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.020_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2025.12.020_bib27","article-title":"Characterization of two heterogeneous lethal mouse-adapted SARS-CoV-2 variants recapitulating representative aspects of human COVID-19","volume":"13","author":"Yan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.12.020_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12866-025-03847-2","article-title":"Taurultam shows antiviral activity against SARS-CoV-2 and influenza virus","volume":"25","author":"Luo","year":"2025","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.apsb.2025.12.020_bib29","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ajpath.2014.02.012","article-title":"Conditional knockout of PIK3C3 causes a murine muscular dystrophy","volume":"184","author":"Reifler","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2025.12.020_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20140889","article-title":"Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase","volume":"463","author":"Bago","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2025.12.020_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/jm5013352","article-title":"Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors","volume":"58","author":"Pasquier","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.020_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/ncb3053","article-title":"Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo","volume":"16","author":"Dowdle","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.020_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nchembio.1681","article-title":"A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy","volume":"10","author":"Ronan","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2025.12.020_bib34","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.12.020_bib35","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2025.12.020_bib36","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.12.020_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2025.12.020_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Jayk","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.12.020_bib39","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1042\/BCJ20160170","article-title":"The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34","volume":"473","author":"Backer","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2025.12.020_bib40","doi-asserted-by":"crossref","first-page":"e58281","DOI":"10.7554\/eLife.58281","article-title":"Membrane characteristics tune activities of endosomal and autophagic human VPS34 complexes","volume":"9","author":"Ohashi","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2025.12.020_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007530","article-title":"Recruitment of Vps34 PI3K and enrichment of PI3P phosphoinositide in the viral replication compartment is crucial for replication of a positive-strand RNA virus","volume":"15","author":"Feng","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2025.12.020_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012444","article-title":"Genome-wide CRISPR\/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection","volume":"20","author":"Gong","year":"2024","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2025.12.020_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41588-021-00805-2","article-title":"Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2","volume":"53","author":"Baggen","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.12.020_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","article-title":"Identification of required host factors for SARS-CoV-2 infection in human cells","volume":"184","author":"Daniloski","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.12.020_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.12.004","article-title":"Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.12.020_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109479","article-title":"Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication","volume":"36","author":"Williams","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.12.020_bib47","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/jmv.26583","article-title":"Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase","volume":"93","author":"Yuen","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.apsb.2025.12.020_bib48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/mp900036s","article-title":"Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys","volume":"6","author":"Durand-Gasselin","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.020_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932934","article-title":"Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models","volume":"13","author":"Hong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.12.020_bib50","first-page":"65","article-title":"Current prodrug strategies for improving oral absorption of nucleoside analogues","volume":"9","author":"Zhang","year":"2014","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2025.12.020_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113862","article-title":"Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus","volume":"226","author":"El-Sayed","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.020_bib52","doi-asserted-by":"crossref","first-page":"12044","DOI":"10.1021\/acs.jmedchem.2c00758","article-title":"Optimization of the prodrug moiety of Remdesivir to improve lung exposure\/selectivity and enhance anti-SARS-CoV-2 activity","volume":"65","author":"Hu","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.12.020_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01155-21","article-title":"Rethinking Remdesivir: synthesis, antiviral activity, and pharmacokinetics of oral lipid prodrugs","volume":"65","author":"Schooley","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2025.12.020_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrendo.2014.35","article-title":"Autophagy\u2012a key player in cellular and body metabolism","volume":"10","author":"Kim","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2025.12.020_bib55","article-title":"Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model","author":"Shan","year":"2025","journal-title":"Acta Pharm Sin B"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:47:08Z","timestamp":1783025228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525008287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383525008287"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.020","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}